Raleigh's Bryn Pharma – developing alternative to needles to fight deadly allergies- raises $11M
The company is working towards FDA approval of its epinephrine nasal spray, named UTULY, for treating anaphylaxis. If successful, it may replace the current anaphylaxis treatment standard, which is the needle-based EPIPEN.
Source: wraltechwire.com